“Wnt5a silencing inhibits the osteosarcoma migration by suppressing PI3K/AKT signaling pathway”, Bangladesh J Pharmacol, vol. 9, no. 4, pp. 533–538, Oct. 2014, doi: 10.3329/bjp.v9i4.20398.